Other Current Liabilities (Details) - USD ($) |
Dec. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Other Liabilities Disclosure [Abstract] | ||
Research and development costs | $ 40,597 | $ 140,953 |
Legal expense | 227,350 | 133,537 |
Insurance loan payable | 55,451 | 0 |
Board fees | 0 | 44,984 |
Deposit - Verdelite SPA | 553,800 | 0 |
Acquisition related contingent liability | 134,896 | 0 |
Total other accrued liabilities | 410,348 | 56,368 |
Total other current liabilities | $ 1,422,442 | $ 375,842 |
X | ||||||||||
- Definition Accrued Board Fees, Current No definition available.
|
X | ||||||||||
- Definition Accrued Research And Development Costs, Current No definition available.
|
X | ||||||||||
- Definition Deposit From Divestment No definition available.
|
X | ||||||||||
- Definition Insurance Loan Payable, Current No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|